Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Sheahan

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Nature Structural & Molecular Biology|August 24, 2021
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genomeKaiming Zhang, Ivan N Zheludev, Rachel J Hagey, et al.
Antiviral Research|November 14, 2024
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral ResearchStephen R Welch, John P Bilello, Kara Carter, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA GenomeKaiming Zhang, Ivan N Zheludev, Rachel J Hagey, et al.
Cell|October 8, 2020
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory MiceSarah R Leist, Kenneth H Dinnon, Alexandra Schäfer, et al.
Science Translational Medicine|December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWilliam A Fischer, Joseph J Eron, Wayne Holman, et al.
Nature|August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Nature|January 20, 2021
Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Science Advances|June 19, 2026
Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravirAsif Rakib, Arnab Das, Subhas C Bera, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Nature Structural & Molecular Biology|August 24, 2021
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genomeKaiming Zhang, Ivan N Zheludev, Rachel J Hagey, et al.
Antiviral Research|November 14, 2024
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral ResearchStephen R Welch, John P Bilello, Kara Carter, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA GenomeKaiming Zhang, Ivan N Zheludev, Rachel J Hagey, et al.
Cell|October 8, 2020
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory MiceSarah R Leist, Kenneth H Dinnon, Alexandra Schäfer, et al.
Science Translational Medicine|December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWilliam A Fischer, Joseph J Eron, Wayne Holman, et al.
Nature|August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Nature|January 20, 2021
Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasuresKenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Science Advances|June 19, 2026
Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravirAsif Rakib, Arnab Das, Subhas C Bera, et al.
Pageof 9